UniProt ID | TRA2A_HUMAN | |
---|---|---|
UniProt AC | Q13595 | |
Protein Name | Transformer-2 protein homolog alpha | |
Gene Name | TRA2A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 282 | |
Subcellular Localization | Nucleus . | |
Protein Description | Sequence-specific RNA-binding protein which participates in the control of pre-mRNA splicing.. | |
Protein Sequence | MSDVEENNFEGRESRSQSKSPTGTPARVKSESRSGSRSPSRVSKHSESHSRSRSKSRSRSRRHSHRRYTRSRSHSHSHRRRSRSRSYTPEYRRRRSRSHSPMSNRRRHTGSRANPDPNTCLGVFGLSLYTTERDLREVFSRYGPLSGVNVVYDQRTGRSRGFAFVYFERIDDSKEAMERANGMELDGRRIRVDYSITKRAHTPTPGIYMGRPTHSGGGGGGGGGGGGGGGGRRRDSYYDRGYDRGYDRYEDYDYRYRRRSPSPYYSRYRSRSRSRSYSPRRY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSDVEENNF ------CCHHHHCCC | 50.82 | 20068231 | |
2 | Phosphorylation | ------MSDVEENNF ------CCHHHHCCC | 50.82 | 29255136 | |
14 | Phosphorylation | NNFEGRESRSQSKSP CCCCCCCCCCCCCCC | 35.55 | 29255136 | |
16 | Phosphorylation | FEGRESRSQSKSPTG CCCCCCCCCCCCCCC | 48.35 | 25159151 | |
18 | Phosphorylation | GRESRSQSKSPTGTP CCCCCCCCCCCCCCC | 36.03 | 25159151 | |
20 | Phosphorylation | ESRSQSKSPTGTPAR CCCCCCCCCCCCCCC | 32.70 | 28355574 | |
22 | Phosphorylation | RSQSKSPTGTPARVK CCCCCCCCCCCCCHH | 61.86 | 29255136 | |
24 | Phosphorylation | QSKSPTGTPARVKSE CCCCCCCCCCCHHCC | 19.09 | 28355574 | |
30 | Phosphorylation | GTPARVKSESRSGSR CCCCCHHCCCCCCCC | 37.64 | 25159151 | |
32 | Phosphorylation | PARVKSESRSGSRSP CCCHHCCCCCCCCCC | 38.55 | 19651622 | |
34 | Phosphorylation | RVKSESRSGSRSPSR CHHCCCCCCCCCCCH | 50.85 | 19651622 | |
36 | Phosphorylation | KSESRSGSRSPSRVS HCCCCCCCCCCCHHH | 30.72 | 28102081 | |
38 | Phosphorylation | ESRSGSRSPSRVSKH CCCCCCCCCCHHHHC | 28.99 | 19651622 | |
40 | Phosphorylation | RSGSRSPSRVSKHSE CCCCCCCCHHHHCCC | 46.70 | 19651622 | |
43 | Phosphorylation | SRSPSRVSKHSESHS CCCCCHHHHCCCCCC | 24.44 | 28985074 | |
46 | Phosphorylation | PSRVSKHSESHSRSR CCHHHHCCCCCCCCC | 44.52 | 26091039 | |
48 | Phosphorylation | RVSKHSESHSRSRSK HHHHCCCCCCCCCCC | 29.76 | 26091039 | |
50 | Phosphorylation | SKHSESHSRSRSKSR HHCCCCCCCCCCCCH | 41.03 | 17081983 | |
64 | Phosphorylation | RSRSRRHSHRRYTRS HHHHHHHHHHHHHHC | 19.51 | 22817900 | |
68 | Phosphorylation | RRHSHRRYTRSRSHS HHHHHHHHHHCCCCC | 13.37 | 24719451 | |
69 | Phosphorylation | RHSHRRYTRSRSHSH HHHHHHHHHCCCCCC | 21.98 | 29449344 | |
71 | Phosphorylation | SHRRYTRSRSHSHSH HHHHHHHCCCCCCCC | 30.27 | 20363803 | |
73 | Ubiquitination | RRYTRSRSHSHSHRR HHHHHCCCCCCCCCC | 30.50 | - | |
73 | Phosphorylation | RRYTRSRSHSHSHRR HHHHHCCCCCCCCCC | 30.50 | 20363803 | |
73 (in isoform 2) | Ubiquitination | - | 30.50 | 21890473 | |
75 | Phosphorylation | YTRSRSHSHSHRRRS HHHCCCCCCCCCCHH | 28.12 | 30242111 | |
77 | Phosphorylation | RSRSHSHSHRRRSRS HCCCCCCCCCCHHHC | 23.00 | 19651622 | |
82 | Phosphorylation | SHSHRRRSRSRSYTP CCCCCCHHHCCCCCH | 32.56 | 20164059 | |
84 | Phosphorylation | SHRRRSRSRSYTPEY CCCCHHHCCCCCHHH | 27.16 | 22167270 | |
86 | Phosphorylation | RRRSRSRSYTPEYRR CCHHHCCCCCHHHHH | 34.31 | 22167270 | |
87 | Phosphorylation | RRSRSRSYTPEYRRR CHHHCCCCCHHHHHH | 25.79 | 22167270 | |
88 | Phosphorylation | RSRSRSYTPEYRRRR HHHCCCCCHHHHHHH | 15.76 | 19664994 | |
91 | Phosphorylation | SRSYTPEYRRRRSRS CCCCCHHHHHHHHCC | 15.60 | 22167270 | |
96 | Phosphorylation | PEYRRRRSRSHSPMS HHHHHHHHCCCCCCC | 36.00 | 22167270 | |
97 (in isoform 2) | Ubiquitination | - | 36.26 | 21890473 | |
97 | Ubiquitination | EYRRRRSRSHSPMSN HHHHHHHCCCCCCCC | 36.26 | - | |
98 | Phosphorylation | YRRRRSRSHSPMSNR HHHHHHCCCCCCCCC | 29.57 | 22167270 | |
100 | Phosphorylation | RRRSRSHSPMSNRRR HHHHCCCCCCCCCCC | 24.44 | 22167270 | |
103 | Phosphorylation | SRSHSPMSNRRRHTG HCCCCCCCCCCCCCC | 30.48 | 22167270 | |
109 | Phosphorylation | MSNRRRHTGSRANPD CCCCCCCCCCCCCCC | 34.73 | 20068231 | |
111 | Phosphorylation | NRRRHTGSRANPDPN CCCCCCCCCCCCCCC | 29.40 | 24719451 | |
119 | Phosphorylation | RANPDPNTCLGVFGL CCCCCCCCEEHHHCE | 17.94 | 20068231 | |
130 | Phosphorylation | VFGLSLYTTERDLRE HHCEEEEECHHHHHH | 27.72 | 20068231 | |
131 | Phosphorylation | FGLSLYTTERDLREV HCEEEEECHHHHHHH | 18.57 | 20068231 | |
140 | Phosphorylation | RDLREVFSRYGPLSG HHHHHHHHHHCCCCC | 29.75 | 24719451 | |
142 | Phosphorylation | LREVFSRYGPLSGVN HHHHHHHHCCCCCEE | 23.15 | 24719451 | |
146 | Phosphorylation | FSRYGPLSGVNVVYD HHHHCCCCCEEEEEE | 43.77 | 24719451 | |
152 | Phosphorylation | LSGVNVVYDQRTGRS CCCEEEEEECCCCCC | 11.32 | 28152594 | |
155 (in isoform 4) | Phosphorylation | - | 35.93 | 28634120 | |
158 (in isoform 4) | Phosphorylation | - | 23.67 | 25849741 | |
160 | Methylation | DQRTGRSRGFAFVYF ECCCCCCCCEEEEEE | 42.77 | 54560267 | |
160 (in isoform 4) | Phosphorylation | - | 42.77 | 25849741 | |
162 (in isoform 4) | Phosphorylation | - | 4.66 | 28842319 | |
164 (in isoform 4) | Phosphorylation | - | 4.23 | 22617229 | |
166 | Phosphorylation | SRGFAFVYFERIDDS CCCEEEEEEEECCCH | 8.02 | - | |
170 (in isoform 4) | Phosphorylation | - | 5.63 | 25849741 | |
173 | Phosphorylation | YFERIDDSKEAMERA EEEECCCHHHHHHHH | 28.75 | 23403867 | |
174 | Acetylation | FERIDDSKEAMERAN EEECCCHHHHHHHHC | 57.39 | 26051181 | |
174 (in isoform 1) | Ubiquitination | - | 57.39 | 21890473 | |
174 | Ubiquitination | FERIDDSKEAMERAN EEECCCHHHHHHHHC | 57.39 | 21906983 | |
188 | Methylation | NGMELDGRRIRVDYS CCCEECCEEEEEEEE | 30.44 | - | |
194 | Phosphorylation | GRRIRVDYSITKRAH CEEEEEEEEEECCCC | 10.10 | 20068231 | |
195 | Phosphorylation | RRIRVDYSITKRAHT EEEEEEEEEECCCCC | 21.22 | 21815630 | |
197 | Phosphorylation | IRVDYSITKRAHTPT EEEEEEEECCCCCCC | 14.45 | 20068231 | |
198 | Ubiquitination | RVDYSITKRAHTPTP EEEEEEECCCCCCCC | 46.01 | 21890473 | |
198 | Ubiquitination | RVDYSITKRAHTPTP EEEEEEECCCCCCCC | 46.01 | 21890473 | |
198 | Sumoylation | RVDYSITKRAHTPTP EEEEEEECCCCCCCC | 46.01 | 28112733 | |
198 (in isoform 1) | Ubiquitination | - | 46.01 | 21890473 | |
198 | Acetylation | RVDYSITKRAHTPTP EEEEEEECCCCCCCC | 46.01 | 25953088 | |
198 | Ubiquitination | RVDYSITKRAHTPTP EEEEEEECCCCCCCC | 46.01 | 21890473 | |
202 | Phosphorylation | SITKRAHTPTPGIYM EEECCCCCCCCCEEC | 28.07 | 29255136 | |
204 | Phosphorylation | TKRAHTPTPGIYMGR ECCCCCCCCCEECCC | 34.99 | 22167270 | |
208 | Phosphorylation | HTPTPGIYMGRPTHS CCCCCCEECCCCCCC | 10.22 | 21945579 | |
213 | Phosphorylation | GIYMGRPTHSGGGGG CEECCCCCCCCCCCC | 27.58 | 23927012 | |
215 | Phosphorylation | YMGRPTHSGGGGGGG ECCCCCCCCCCCCCC | 41.43 | 25159151 | |
232 | Methylation | GGGGGGGRRRDSYYD CCCCCCCCCCCCCCC | 33.46 | - | |
236 | Phosphorylation | GGGRRRDSYYDRGYD CCCCCCCCCCCCCCC | 24.63 | 23401153 | |
237 | Phosphorylation | GGRRRDSYYDRGYDR CCCCCCCCCCCCCCC | 17.42 | 20044836 | |
238 | Phosphorylation | GRRRDSYYDRGYDRG CCCCCCCCCCCCCCC | 11.78 | 24702127 | |
240 | Methylation | RRDSYYDRGYDRGYD CCCCCCCCCCCCCCC | 29.47 | 115918877 | |
246 | Phosphorylation | DRGYDRGYDRYEDYD CCCCCCCCCCCCCCC | 9.72 | 28796482 | |
249 | Phosphorylation | YDRGYDRYEDYDYRY CCCCCCCCCCCCHHH | 15.39 | 28796482 | |
252 | Phosphorylation | GYDRYEDYDYRYRRR CCCCCCCCCHHHHCC | 11.70 | 28796482 | |
254 | Phosphorylation | DRYEDYDYRYRRRSP CCCCCCCHHHHCCCC | 11.87 | 28796482 | |
255 | Asymmetric dimethylarginine | RYEDYDYRYRRRSPS CCCCCCHHHHCCCCC | 18.65 | - | |
255 | Methylation | RYEDYDYRYRRRSPS CCCCCCHHHHCCCCC | 18.65 | - | |
256 | Phosphorylation | YEDYDYRYRRRSPSP CCCCCHHHHCCCCCC | 11.40 | - | |
260 | Phosphorylation | DYRYRRRSPSPYYSR CHHHHCCCCCCCHHH | 28.11 | 26846344 | |
262 | Phosphorylation | RYRRRSPSPYYSRYR HHHCCCCCCCHHHHH | 27.12 | 19664994 | |
264 | Phosphorylation | RRRSPSPYYSRYRSR HCCCCCCCHHHHHCC | 20.57 | 20201521 | |
265 | Phosphorylation | RRSPSPYYSRYRSRS CCCCCCCHHHHHCCC | 7.05 | 23927012 | |
266 | Phosphorylation | RSPSPYYSRYRSRSR CCCCCCHHHHHCCCC | 19.59 | 26846344 | |
268 | Phosphorylation | PSPYYSRYRSRSRSR CCCCHHHHHCCCCCC | 13.65 | 25884760 | |
270 | Phosphorylation | PYYSRYRSRSRSRSY CCHHHHHCCCCCCCC | 26.18 | 29116813 | |
272 | Phosphorylation | YSRYRSRSRSRSYSP HHHHHCCCCCCCCCC | 35.54 | 26846344 | |
274 | Phosphorylation | RYRSRSRSRSYSPRR HHHCCCCCCCCCCCC | 27.16 | 26846344 | |
276 | Phosphorylation | RSRSRSRSYSPRRY- HCCCCCCCCCCCCC- | 31.07 | 26846344 | |
277 | Phosphorylation | SRSRSRSYSPRRY-- CCCCCCCCCCCCC-- | 22.91 | 26846344 | |
278 | Phosphorylation | RSRSRSYSPRRY--- CCCCCCCCCCCC--- | 17.12 | 28355574 | |
282 | Phosphorylation | RSYSPRRY------- CCCCCCCC------- | 24.96 | 21406692 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TRA2A_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TRA2A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TRA2A_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-262, ANDMASS SPECTROMETRY. | |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-14; THR-202;THR-204; SER-260 AND SER-262, AND MASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-84; SER-86; THR-88;THR-202; THR-204; SER-215; SER-260 AND SER-262, AND MASS SPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-262, ANDMASS SPECTROMETRY. | |
"Improved titanium dioxide enrichment of phosphopeptides from HeLacells and high confident phosphopeptide identification by cross-validation of MS/MS and MS/MS/MS spectra."; Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.; J. Proteome Res. 6:4150-4162(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-262, ANDMASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-260 AND SER-262, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; SER-14; SER-16;SER-18; SER-84; SER-86; THR-88; SER-96; SER-98; SER-100 AND THR-204,AND MASS SPECTROMETRY. | |
"Global phosphoproteome analysis on human HepG2 hepatocytes usingreversed-phase diagonal LC."; Gevaert K., Staes A., Van Damme J., De Groot S., Hugelier K.,Demol H., Martens L., Goethals M., Vandekerckhove J.; Proteomics 5:3589-3599(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2, AND MASSSPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-264 AND TYR-265, ANDMASS SPECTROMETRY. |